Movicol Paediatric Plain Sachet

Macrogol 3350 and electrolytes, the active ingredient in Movicol Paediatric Plain Sachet, is an osmotic laxative presented as an oral sachet for oral use. It softens stool and helps relieve constipation in children, including functional and chronic forms. GNH USA supplies Movicol Paediatric Plain Sachet as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Movicol Paediatric Plain Sachet is an osmotic laxative used to manage constipation in the pediatric population. - Constipation: softens stool and facilitates bowel movements in children with functional or chronic constipation. - Functional constipation: improves stool consistency and reduces abdominal discomfort associated with functional bowel disorders. - Opioid‑induced constipation: restores normal bowel function in children receiving opioid therapy.

Common Side Effects: - Abdominal bloating: mild distension of the abdomen. - Flatulence: increased intestinal gas. - Nausea: feeling of queasiness. - Diarrhoea: loose stools occurring more frequently.

Serious or Rare Side Effects: - Severe abdominal pain: intense, persistent pain requiring medical attention. - Electrolyte imbalance: abnormal levels of sodium, potassium or chloride. - Allergic reaction: rash, itching, swelling or difficulty breathing.

Before using Movicol Paediatric Plain Sachet, consider the following precautions: - Assess hydration status: ensure the child is adequately hydrated before initiating therapy. - Monitor electrolyte balance: check serum electrolytes in children with renal or cardiac conditions. - Use with caution in renal impairment: adjust use if kidney function is reduced. - Avoid in known hypersensitivity: discontinue if allergic reactions occur. - Store at room temperature: keep in the original pack, protect from moisture.

Movicol Paediatric Plain Sachet may interact with other medicines as follows: Major Interactions (Avoid): - Concurrent osmotic laxatives: risk of excessive fluid loss and electrolyte disturbances. - High‑dose potassium supplements: may cause hyperkalaemia.

Moderate Interactions (Monitor Closely): - Anticholinergic agents: may reduce laxative efficacy. - Diuretics: can affect electrolyte balance and fluid status. - Lithium: potential alteration of lithium serum concentrations.